Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
NEK9
Introduction
Serine/threonine-protein kinase Nek9 is an enzyme that in humans is encoded by the NEK9 gene.[1][2]
Model organisms
Model organisms
Model organisms have been used in the study of NEK9 function. A conditional knockout mouse line called Nek9tm1a(EUCOMM)Wtsi was generated at the Wellcome Trust Sanger Institute.[7] Male and female animals underwent a standardized phenotypic screen[8] to determine the effects of deletion.[9][10][11][12] Additional screens performed: – In-depth immunological phenotyping[13]
| Characteristic | Phenotype | |
|---|---|---|
| All data available at.[8][13] | Peripheral blood leukocytes 6 Weeks | Normal |
| Insulin | Normal | |
| Haematology 6 Weeks | Normal | |
| Homozygous viability at P14 | Abnormal | |
| Recessive lethal study | Abnormal | |
| Body weight | Normal | |
| Neurological assessment | Normal | |
| Grip strength | Normal | |
| Dysmorphology | Normal | |
| Indirect calorimetry | Normal | |
| Glucose tolerance test | Normal | |
| Auditory brainstem response | Normal | |
| DEXA | Normal | |
| Radiography | Normal | |
| Eye morphology | Normal | |
| Clinical chemistry | Normal | |
| Haematology 16 Weeks | Normal | |
| Peripheral blood leukocytes 16 Weeks | Normal | |
| Heart weight | Normal | |
| Salmonella infection | Normal | |
| Cytotoxic T Cell Function | Normal | |
| Spleen Immunophenotyping | Normal | |
| Mesenteric Lymph Node Immunophenotyping | Normal | |
| Bone Marrow Immunophenotyping | Normal | |
| Epidermal Immune Composition | Normal |
References
References
- ↑ Holland PM, Milne A, Garka K, Johnson RS, Willis C, Sims JE, Rauch CT, Bird TA, Virca GD (May 2002). “Purification, cloning, and characterization of Nek8, a novel NIMA-related kinase, and its candidate substrate Bicd2”. The Journal of Biological Chemistry. 277 (18): 16229–40. doi:10.1074/jbc.M108662200. PMID 11864968.
- ↑ “Entrez Gene: NEK9 NIMA (never in mitosis gene a)- related kinase 9”.
- ↑ Ewing RM, Chu P, Elisma F, Li H, Taylor P, Climie S, McBroom-Cerajewski L, Robinson MD, O’Connor L, Li M, Taylor R, Dharsee M, Ho Y, Heilbut A, Moore L, Zhang S, Ornatsky O, Bukhman YV, Ethier M, Sheng Y, Vasilescu J, Abu-Farha M, Lambert JP, Duewel HS, Stewart II, Kuehl B, Hogue K, Colwill K, Gladwish K, Muskat B, Kinach R, Adams SL, Moran MF, Morin GB, Topaloglou T, Figeys D (2007). “Large-scale mapping of human protein-protein interactions by mass spectrometry”. Molecular Systems Biology. 3: 89. doi:10.1038/msb4100134. PMC 1847948. PMID 17353931.
- ↑ Belham C, Roig J, Caldwell JA, Aoyama Y, Kemp BE, Comb M, Avruch J (Sep 2003). “A mitotic cascade of NIMA family kinases. Nercc1/Nek9 activates the Nek6 and Nek7 kinases”. The Journal of Biological Chemistry. 278 (37): 34897–909. doi:10.1074/jbc.M303663200. PMID 12840024.
- ↑ 5.0 5.1 Roig J, Mikhailov A, Belham C, Avruch J (Jul 2002). “Nercc1, a mammalian NIMA-family kinase, binds the Ran GTPase and regulates mitotic progression”. Genes & Development. 16 (13): 1640–58. doi:10.1101/gad.972202. PMC 186374. PMID 12101123.
- ↑ Tan BC, Lee SC (Mar 2004). “Nek9, a novel FACT-associated protein, modulates interphase progression”. The Journal of Biological Chemistry. 279 (10): 9321–30. doi:10.1074/jbc.M311477200. PMID 14660563.
- ↑ Gerdin AK (2010). “The Sanger Mouse Genetics Programme: high throughput characterisation of knockout mice”. Acta Ophthalmologica. 88: 925–7. doi:10.1111/j.1755-3768.2010.4142.x.
- ↑ 8.0 8.1 “International Mouse Phenotyping Consortium”.
- ↑ Skarnes WC, Rosen B, West AP, Koutsourakis M, Bushell W, Iyer V, Mujica AO, Thomas M, Harrow J, Cox T, Jackson D, Severin J, Biggs P, Fu J, Nefedov M, de Jong PJ, Stewart AF, Bradley A (Jun 2011). “A conditional knockout resource for the genome-wide study of mouse gene function”. Nature. 474 (7351): 337–42. doi:10.1038/nature10163. PMC 3572410. PMID 21677750.
- ↑ Dolgin E (Jun 2011). “Mouse library set to be knockout”. Nature. 474 (7351): 262–3. doi:10.1038/474262a. PMID 21677718.
- ↑ Collins FS, Rossant J, Wurst W (Jan 2007). “A mouse for all reasons”. Cell. 128 (1): 9–13. doi:10.1016/j.cell.2006.12.018. PMID 17218247.
- ↑ White JK, Gerdin AK, Karp NA, Ryder E, Buljan M, Bussell JN, Salisbury J, Clare S, Ingham NJ, Podrini C, Houghton R, Estabel J, Bottomley JR, Melvin DG, Sunter D, Adams NC, Tannahill D, Logan DW, Macarthur DG, Flint J, Mahajan VB, Tsang SH, Smyth I, Watt FM, Skarnes WC, Dougan G, Adams DJ, Ramirez-Solis R, Bradley A, Steel KP (Jul 2013). “Genome-wide generation and systematic phenotyping of knockout mice reveals new roles for many genes”. Cell. 154 (2): 452–64. doi:10.1016/j.cell.2013.06.022. PMC 3717207. PMID 23870131.
- ↑ 13.0 13.1 “Infection and Immunity Immunophenotyping (3i) Consortium”.
Further reading
Further reading
- Pelka P, Scimè A, Mandalfino C, Joch M, Abdulla P, Whyte P (Jul 2007). “Adenovirus E1A proteins direct subcellular redistribution of Nek9, a NimA-related kinase”. Journal of Cellular Physiology. 212 (1): 13–25. doi:10.1002/jcp.20983. PMID 17443675.
- Ewing RM, Chu P, Elisma F, Li H, Taylor P, Climie S, McBroom-Cerajewski L, Robinson MD, O’Connor L, Li M, Taylor R, Dharsee M, Ho Y, Heilbut A, Moore L, Zhang S, Ornatsky O, Bukhman YV, Ethier M, Sheng Y, Vasilescu J, Abu-Farha M, Lambert JP, Duewel HS, Stewart II, Kuehl B, Hogue K, Colwill K, Gladwish K, Muskat B, Kinach R, Adams SL, Moran MF, Morin GB, Topaloglou T, Figeys D (2007). “Large-scale mapping of human protein-protein interactions by mass spectrometry”. Molecular Systems Biology. 3 (1): 89. doi:10.1038/msb4100134. PMC 1847948. PMID 17353931.
- Wissing J, Jänsch L, Nimtz M, Dieterich G, Hornberger R, Kéri G, Wehland J, Daub H (Mar 2007). “Proteomics analysis of protein kinases by target class-selective prefractionation and tandem mass spectrometry”. Molecular & Cellular Proteomics. 6 (3): 537–47. doi:10.1074/mcp.T600062-MCP200. PMID 17192257.
- Olsen JV, Blagoev B, Gnad F, Macek B, Kumar C, Mortensen P, Mann M (Nov 2006). “Global, in vivo, and site-specific phosphorylation dynamics in signaling networks”. Cell. 127 (3): 635–48. doi:10.1016/j.cell.2006.09.026. PMID 17081983.
- Bowers AJ, Boylan JF (Mar 2004). “Nek8, a NIMA family kinase member, is overexpressed in primary human breast tumors”. Gene. 328: 135–42. doi:10.1016/j.gene.2003.12.002. PMID 15019993.
- Tan BC, Lee SC (Mar 2004). “Nek9, a novel FACT-associated protein, modulates interphase progression”. The Journal of Biological Chemistry. 279 (10): 9321–30. doi:10.1074/jbc.M311477200. PMID 14660563.
- Belham C, Roig J, Caldwell JA, Aoyama Y, Kemp BE, Comb M, Avruch J (Sep 2003). “A mitotic cascade of NIMA family kinases. Nercc1/Nek9 activates the Nek6 and Nek7 kinases”. The Journal of Biological Chemistry. 278 (37): 34897–909. doi:10.1074/jbc.M303663200. PMID 12840024.
- Roig J, Mikhailov A, Belham C, Avruch J (Jul 2002). “Nercc1, a mammalian NIMA-family kinase, binds the Ran GTPase and regulates mitotic progression”. Genes & Development. 16 (13): 1640–58. doi:10.1101/gad.972202. PMC 186374. PMID 12101123.
- Ohara O, Nagase T, Mitsui G, Kohga H, Kikuno R, Hiraoka S, Takahashi Y, Kitajima S, Saga Y, Koseki H (Apr 2002). “Characterization of size-fractionated cDNA libraries generated by the in vitro recombination-assisted method”. DNA Research. 9 (2): 47–57. doi:10.1093/dnares/9.2.47. PMID 12056414.